CN111249623A - Rotary magnetic rehabilitation instrument - Google Patents

Rotary magnetic rehabilitation instrument Download PDF

Info

Publication number
CN111249623A
CN111249623A CN202010106241.XA CN202010106241A CN111249623A CN 111249623 A CN111249623 A CN 111249623A CN 202010106241 A CN202010106241 A CN 202010106241A CN 111249623 A CN111249623 A CN 111249623A
Authority
CN
China
Prior art keywords
probe
human body
wave
induction coil
micro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010106241.XA
Other languages
Chinese (zh)
Inventor
王世杰
王振
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010106241.XA priority Critical patent/CN111249623A/en
Publication of CN111249623A publication Critical patent/CN111249623A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00Magnetotherapy
    • A61N2/12Magnetotherapy using variable magnetic fields obtained by mechanical movement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H23/00Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
    • A61H23/02Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H39/00Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H39/00Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
    • A61H39/04Devices for pressing such points, e.g. Shiatsu or Acupressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00Magnetotherapy
    • A61N2/004Magnetotherapy specially adapted for a specific therapy
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01FMAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F5/00Coils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/12Driving means
    • A61H2201/1207Driving means with electric or magnetic drive

Abstract

The embodiment of the disclosure discloses a gyromagnetic rehabilitation therapy instrument, and one specific implementation mode comprises a control circuit, at least one first probe and at least one second probe, wherein the control circuit is electrically connected with the first probe and the second probe and is used for providing working voltage; the first probe comprises a shell, a human body contact surface, a multi-micro-element sheet, a magnet, an induction coil, a wave absorbing element and a rotating device; wherein, the rotating device drives the magnet to rotate to generate a rotating magnetic field; the second probe comprises a shell, a multi-micro-element sheet, an induction coil and a wave-absorbing element; the multiple micro-element pieces are arranged between the induction coil and the contact surface of the human body, and the wave-absorbing element absorbs electromagnetic wave energy projected to the surface of the wave-absorbing material and shields an external magnetic field. The present disclosure uses a rotating magnetic field and a multi-micro energy field to gradually penetrate and stimulate acupuncture points, promote the body channels and collaterals, blood and cells to generate resonance, stimulate and strengthen blood circulation, and enhance the absorption and self-repair capacity of nerve tissues.

Description

Rotary magnetic rehabilitation instrument
Technical Field
The present disclosure relates to the field of medical equipment technology, and in particular, to a gyromagnetic rehabilitation apparatus.
Background
Diabetes Mellitus (DM) is a group of carbohydrate, protein and fat metabolism disorder diseases caused by absolute or relative insufficient secretion and/or insulin utilization disorder of insulin, and takes hyperglycemia as a main marker. Insufficient insulin secretion leads to an increase in blood sugar, which leads to diabetic ketoacidosis, diabetic lactic acidosis, and acute complications such as diabetic hyperosmolar coma or hyperosmolar state. And chronic complications caused by diabetes, such as cerebrovascular accident, diabetic eye disease, diabetic heart disease, diabetic retinopathy, etc.
Disclosure of Invention
The purpose of the present disclosure is to provide a gyromagnetic rehabilitation therapy apparatus, to solve the technical problems in the prior art, which gradually permeates to the physical therapy part through the rotating magnetic field and the multi-micro energy field with various elements required by the human body, to enhance the metabolism of the human body, and to help the human body to recover the normal physiological function.
In order to achieve the above object, the present disclosure provides a gyromagnetic rehabilitation therapy apparatus, comprising: the device comprises a control circuit and at least one first probe and at least one second probe, wherein the control circuit is electrically connected with the first probe and the second probe so as to respectively provide working voltage for the first probe and the second probe; the first probe comprises a first shell, a first human body contact surface arranged on the first shell and used for contacting with a human body, a first multi-micro-element sheet arranged in the first shell and positioned on one side of the human body contact surface, a magnet and a motor; the motor is connected with the magnet, and the motor drives the magnet to rotate when rotating to generate a rotating magnetic field; at least one first induction coil and at least one first wave-absorbing element are arranged on at least one side of the motor, the first induction coil is used for generating heat and corresponds to the first wave-absorbing element one by one, the first multi-micro-element sheet is arranged between the first induction coil and the human body contact surface and consists of multiple trace elements required by a human body, and the first wave-absorbing element is used for absorbing electromagnetic waves projected to the surface of the first wave-absorbing element and shielding an external magnetic field, wherein the electromagnetic waves are generated after the first induction coil is electrified; the second probe comprises a second shell, a second human body contact surface arranged on the second shell and used for contacting a human body, a second multi-micro-element sheet arranged in the second shell and positioned on one side of the second human body contact surface, a second induction coil and a second wave-absorbing element made of wave-absorbing materials; the second multi-micro-element sheet is arranged between the second induction coil and the second human body contact surface, the second multi-micro-element sheet is composed of multiple trace elements required by a human body, the second wave absorbing element is used for absorbing electromagnetic wave energy projected to the surface of the wave absorbing material and shielding an external magnetic field, and the second induction coil is used for generating heat and corresponds to the second wave absorbing element one by one; the second induction coil is used for converting electric energy into heat energy, and the electromagnetic waves are generated after the second induction coil is electrified.
Optionally, the number of the first probe and the second probe is one and four, respectively.
Optionally, the action positions of the first probe and the second probe correspond to acupuncture points of a human body.
Optionally, the above-mentioned multiple trace elements required by human body include: chromium, zinc, magnesium, calcium, vanadium, iron, selenium, silicon, molybdenum, nickel, iodine, copper, manganese, folic acid, carotene, potassium, phosphorus, chlorine, iron, germanium, cobalt, iron folic acid-, vitamin a, vitamin B1, B2, B3, B6, B12, vitamin C, vitamin D, vitamin E, and rare earth elements.
Optionally, the weight ratio of the above-mentioned trace elements required by human body to the trace element plate may be selected from the following ranges: 5-95 percent of chromium, 5-95 percent of zinc, 5-95 percent of magnesium, 5-95 percent of calcium, 5-95 percent of vanadium, 5-95 percent of iron, 5-95 percent of selenium, 5-95 percent of silicon, 5-95 percent of molybdenum, 5-95 percent of nickel, 5-95 percent of iodine, 5-95 percent of copper, 5-95 percent of manganese, 5-95 percent of folic acid, 5-95 percent of carotene, 5-95 percent of potassium, 5-95 percent of phosphorus, 5-95 percent of chlorine, 5-95 percent of iron, 5-95 percent of germanium, 5-95 percent of cobalt, 5-95 percent of iron folic acid, 5-95 percent of vitamin A, Vitamin B1 (5% -95%), B2 (5% -95%), B3 (5% -95%), B6 (5% -95%), B12 (5% -95%), vitamin C (5% -95%), vitamin D (5% -95%), vitamin E (5% -95%) and rare earth elements (5% -95%). Preferably, the weight ratio of the multiple trace elements required by the human body to the trace element plate is as follows: chromium (4%), zinc (4%), magnesium (4%), calcium (4%), vanadium (4%), iron (4%), selenium (4%), silicon (4%), molybdenum (4%), nickel (4%), iodine (4%), copper (4%), manganese (4%), folic acid (2%), carotene (1%), potassium (2.5%), phosphorus (2.5%), chlorine (2.5%), iron (2.5%), germanium (2.5%), cobalt (2.5%), iron folic acid (2.5%), vitamin a (2.5%), vitamin B1 (2.5%), B2 (2.5%), B3 (2.5%), B6 (2.5%), B12 (2.5%), vitamin C (2.5%), vitamin D (2.5%), vitamin E (2.5%) and rare earth elements (1%).
Optionally, the control circuit includes at least one digital potentiometer, and the digital potentiometer adjusts an operating voltage output by the control circuit to the first probe and/or the second probe according to a control signal received by the control circuit and sent by a user to perform a temperature adjustment operation on the first probe and/or the second probe, so as to control heat generated by an induction coil in at least one of the first probe and/or at least one of the second probe.
Optionally, the motor is a brushless motor, and the rotation speed v: v is more than or equal to 3000 r/min and less than 5000 r/min.
Optionally, the induction coil generates heat after being electrified, and the heat is transferred by means of heat radiation; the heat transferred in the way of heat radiation acts on the first multi-micro-element sheet and/or the second multi-micro-element sheet to generate a multi-micro energy field containing various elements required by the human body.
Optionally, the first wave absorbing element and the second wave absorbing element have a U-shaped longitudinal section, and the U-shaped opening faces the human body contact surface; the wave absorbing element partially surrounds the induction coil.
Optionally, the magnet is a circular wheel fixed on an output shaft of the motor, and a central point of the circular wheel deviates from a rotation point of the circular wheel; when the motor rotates, the magnet is driven to rotate, and vibration is generated.
Optionally, the surface of the human body contacting surface is provided with a plurality of protrusions.
On the basis of traditional acupuncture medicine, the present disclosure absorbs the disciplines of electronics, physics, energetics, neuroscience, etc., integrates the multidisciplinary high-end technology into a whole, and combines with various trace elements according to scientific proportion. The rotating magnetic field and the multi-micro energy field are utilized, the probes of the instrument respectively act on a plurality of acupuncture points of a human body, the biological effect of the human body is adjusted, the activity of visceral tissue cells is improved, the autoimmune function and the self-repairing capability are enhanced, the metabolic disorder of sugar, protein and fat is improved, the metabolic balance of the body is realized, and main meridian acupuncture points of the human body are further stimulated by vibrating and massaging the acupuncture points, so that the meridians and collaterals and blood of the human body are promoted to further absorb trace elements, the blood circulation is stimulated, and the absorption and self-repairing capability of nervous tissues are enhanced.
Drawings
The accompanying drawings are included to provide a better understanding of the present disclosure, and are not to be construed as limiting the present disclosure in any way, wherein:
fig. 1 is a schematic structural view of a gyromagnetic rehabilitation apparatus according to an embodiment of the present disclosure;
fig. 2 is a schematic structural diagram of a first probe in the gyromagnetic rehabilitation apparatus according to the embodiment of the present disclosure;
fig. 3 is a schematic structural diagram of a second probe in the gyromagnetic rehabilitation apparatus according to the embodiment of the present disclosure.
Detailed Description
Embodiments of the present disclosure will be described in more detail below with reference to the accompanying drawings. While certain embodiments of the present disclosure are shown in the drawings, it is to be understood that the disclosed invention may be embodied in various forms and should not be construed as limited to the embodiments set forth herein, but rather are provided for a more thorough and complete understanding of the present disclosure. It should be understood that the drawings and embodiments of the disclosure are for illustration purposes only and are not intended to limit the scope of the disclosure.
It should be understood that the various steps recited in the method embodiments of the present disclosure may be performed in a different order, and/or combined. Moreover, method embodiments may perform additional steps and/or omit performing the illustrated steps. The scope of the present disclosure is not limited in this respect. The term 'include' and its variants, as used herein, are open-ended, i.e. 'include, but are not limited to'. The term 'based on' is 'based, at least in part, on'. The term 'one embodiment' means 'at least one embodiment'; the term 'another embodiment' means 'at least one further embodiment'; the term 'some embodiments' means 'at least some embodiments'. Relevant definitions for other terms will be given in the following description.
It should be noted that the terms "first", "second", etc. mentioned in the disclosure are only used for distinguishing different devices, modules or units, and are not used for limiting the sequence or interdependence of the functions executed by the devices, modules or units.
It is noted that references to 'a' or 'a' modification in this disclosure are illustrative rather than limiting and that those skilled in the art will understand that reference to 'one or more' unless the context clearly dictates otherwise.
It should be noted that the embodiments and features of the embodiments of the present disclosure may be combined with each other without conflict.
Please refer to fig. 1, fig. 2, and fig. 3 for understanding. Fig. 1 is a schematic structural view of a gyromagnetic rehabilitation apparatus according to an embodiment of the present disclosure; fig. 2 is a schematic structural diagram of a first probe in the gyromagnetic rehabilitation apparatus according to the embodiment of the disclosure; fig. 3 is a schematic structural diagram of a second probe in the gyromagnetic rehabilitation apparatus according to the embodiment of the disclosure. Fig. 2 and 3 respectively show structural schematic diagrams of the first probe and the second probe, which are observed in a direction perpendicular to a horizontal plane, in which top portions of the first wave-absorbing element 204 and the second wave-absorbing element 303 are removed.
The disclosed gyromagnetic rehabilitation therapy apparatus includes: a control circuit 101 and at least one first probe 102 and at least one second probe 103. The control circuit 101 may be electrically connected to the first probe 102 and the second probe 103 to supply operating voltages to the first probe 102 and the second probe 103, respectively.
The first probe 102 includes a first housing 201, a first human body contact surface 205 provided on the first housing 201 for contacting a human body, and a first multi-micro-element plate 202, a magnet 206, and a motor 207 provided in the first housing on a side of the human body contact surface 205. The motor 207 is connected to a magnet 206. The magnet 206 is a circular wheel fixed to an output shaft of the motor 207, and a center point of the circular wheel is offset from a rotation point of the circular wheel. The motor rotates to drive the magnet 206 to rotate, thereby generating a rotating magnetic field. In addition, since the magnet 206 does not rotate around its center, the magnet 206 may vibrate the motor 207 during the rotation, and the motor 207 is fixed to the first probe 102, so as to vibrate the first probe 102. At least one first induction coil 203 and at least one first wave absorbing element 204 are disposed on at least one side of the motor 207, and the first induction coil 203 is used for generating heat and corresponds to the first wave absorbing element 204 one by one. The first multi-micro-element sheet 202 is disposed between the first induction coil and the human body contact surface 205, wherein the multi-micro-element sheet 202 may be composed of a plurality of trace elements required by the human body. For example, the multi-microelement tablets may contain 28 human-required trace elements, including chromium, zinc, magnesium, calcium, vanadium, iron, selenium, silicon, molybdenum, nickel, iodine, copper, manganese, folic acid, carotene-, potassium, phosphorus, chlorine, iron, germanium, cobalt, iron folate-, vitamin a, vitamin B1, B2, B3, B6, B12, vitamin C, vitamin D, vitamin E, and rare earth elements. The first absorbing element 204 has a U-shaped longitudinal section. The U-shaped opening faces the first human body contact surface. The first absorbing element is used for absorbing the electromagnetic waves projected to the surface of the first absorbing element 204 and can shield an external magnetic field. The electromagnetic wave is generated by the first induction coil 203 being energized.
For example, heat is generated when the first induction coil 203 passes a current. The heat is transferred by means of heat radiation. The heat transferred by the heat radiation method acts on the first multi-micro-element sheet 202 provided in the first casing 201 and located on the first human body contact surface 205 side. The first multi-micro-element sheet 202 generates a multi-micro energy field containing 28 elements necessary for the human body by the heat radiation. The multi-micro energy field is an electromagnetic wave transmitted by means of heat radiation. The multiple micro energy fields act on the acupuncture points of the human body. Further, the first suction element may partially surround the first induction coil. The multiple micro-energy fields not emitted in the direction of the first human body contact surface 205 are absorbed by the first absorption element 204. The first wave-absorbing element 204 is also used to shield external magnetic field and prevent electromagnetic wave in the first probe 102 from external electromagnetic interference. The motor 207 rotates the magnet 206 connected to the motor to generate a rotating magnetic field. In addition, since the center of the magnet 206 is deviated from the rotation point and the motor 206 is fixed to the first probe 102, when the magnet rotates eccentrically, the motor 206 vibrates and drives the first probe 102 to vibrate. The vibration may vibrate the first human body contact surface 205. Wherein, a plurality of bulges can be arranged on the surface of the first human body contact surface. When the first human body contact surface 205 with the plurality of protrusions vibrates, if the first human body contact surface contacts with acupuncture points of a human body, the plurality of protrusions on the first human body contact surface 205 can play a role in massaging the acupuncture points. The rotation speed of the motor 207 may be v: v is more than or equal to 3000 r/min and less than 5000 r/min. The motor speed may be determined by the operating voltage output by the control circuit 101 of fig. 1.
The second probe 103 may include a second shell 301, a second human body contact surface 305 disposed on the second shell 301 for contacting a human body, a second multi-micro-element sheet 304 disposed in the second shell 301 and located on one side of the second human body contact surface 305, a second induction coil 302, and a second wave-absorbing element 303 made of wave-absorbing material. The second multi-micro-element sheet 304 is disposed between the second induction coil 302 and the second human body contact surface 305. The second multi-microelement sheet 304 may be composed of various trace elements required by the human body. For example, the multi-microelement tablet may contain 28 trace elements required by the human body. For example, the multi-microelement tablet may contain 28 trace elements required by the human body, including chromium, zinc, magnesium, calcium, vanadium, iron, selenium, silicon, molybdenum, nickel, iodine, copper, manganese, folic acid, carotene, potassium, phosphorus, chlorine, iron, germanium, cobalt, iron folic acid-, vitamin a, vitamin B1, B2, B3, B6, B12, vitamin C, vitamin D, vitamin E, and rare earth elements. The longitudinal section of the second wave absorbing element 303 is U-shaped. The U-shaped opening may face the second human body contact surface 305. Furthermore, the second wave absorbing element 303 may partially surround the second induction coil 302. The second wave absorbing element 303 is configured to absorb electromagnetic waves projected onto a surface of the second wave absorbing element 303 and further shield an external magnetic field, and the second induction coil 302 is configured to generate heat and corresponds to the second wave absorbing element 303 one to one; the second induction coil 302 is used for converting electric energy into heat energy. The electromagnetic wave is generated by the second induction coil 302 being energized.
For example, heat is generated when the second induction coil 302 passes a current. The heat may be transferred by heat radiation. Heat energy transferred in the form of heat radiation may be applied to the second multi-micro-element sheet 303. The second multi-micro-element sheet 303 is heated to generate a multi-micro energy field containing 28 elements required by the human body, and the multi-micro energy field acts on the acupuncture points of the human body. The second wave absorbing element 303 may absorb the multiple micro energy fields not emitted towards the second human body contact surface, preventing the multiple micro energy fields from leaking and shielding external magnetic field interference.
The second human body contact surface 305 has a plurality of protrusions on its surface. The second human body contact surface 305 provided with a plurality of protrusions is contacted with the acupuncture points of the human body, and the plurality of protrusions on the second human body contact surface 305 can play a role in massaging the acupuncture points. When the gyromagnetic rehabilitation therapy instrument provided by the present disclosure is in an operating state, the control circuit 101 may provide an operating voltage to the first probe 102 and/or the second probe 103. The control circuit 101 includes at least one digital potentiometer 1011. The digital potentiometer 1011 may correspond to the first probe, or the digital potentiometer 1011 may correspond to the second probe.
The maximum operating voltage values of the operating voltages supplied to the first probe 102 and the second probe 103 by the control circuit 101 do not exceed the rated voltages of the first probe 102 and the second probe 103, respectively.
If the user performs a temperature adjustment operation on the first probe 102 and/or the second probe 103 of the gyromagnetic rehabilitation apparatus provided by the present disclosure, the digital potentiometer 1011 adjusts the operating voltage output by the control circuit to the first probe 102 and/or the second probe 103 according to a control signal received by the control circuit 101 and used for performing a temperature adjustment operation on the first probe 102 and/or the second probe 103 by the user, so as to control the heat generated by the induction coil of the first probe 102 and/or the second probe 103.
The control circuit 101 may receive a control signal for a user to adjust the temperature of the first probe a and/or the second probe B, for example, the user may adjust the temperature of the first probe a and the second probe B to 45 ℃ and 50 ℃, respectively. The digital potentiometer 1011 adjusts the operating voltage output from the control circuit 101 to the first probe a and the second probe B in response to the received control signal. Since the internal resistance of the probe does not change, the current in the induction coils of the first probe a and the second probe B changes. Thereby bringing the temperature of the probe A, B to the control signal requirements. Therefore, the user can adjust the temperature of the probe according to the feeling of the user.
In some alternative embodiments, the number of the first probe 102 and the second probe 103 is one. The action positions of the first probe 102 and the second probe 103 can be corresponding to the acupuncture points of the human body.
In some alternative embodiments, the number of the first probe 102 and the second probe 103 is one and four, respectively. Wherein, the action positions of the first probe 102 and the second probe 103 correspond to the acupuncture points of the human body.
In some application scenarios, the gyromagnetic rehabilitation apparatus provided by the present disclosure may include one first probe 102 and four second probes 103. A first probe 102 such as probe a. A second probe such as probe B, C, D, D'.
The probe A acts on the Mingmen and Shenshu acupoints of human body, and through the gradual penetration of rotating magnetic field, vibration and multiple micro-energy fields, the metabolism of kidney cells is accelerated, so that qi, blood and body fluids 'flow into viscera, and externally nourish the skin and skin striae', and the normal physiological function is recovered.
The probe B can be placed at the projection position of pancreas (Qimen acupoint and Riyue acupoint), so that the damaged pancreatic cells can be repaired under the action of the energy field of the probe B. The blood oxygen metabolism of the islet tissue is enhanced, the glucose tolerance factor is stabilized, and the gene action of the glucose carrier is effectively increased. Improve the microcirculation of islet cells and promote normal division and propagation of islet cells. In addition, because of the special frequency of the probe B, the sympathetic nerve of a patient is inhibited in treatment, and parasympathetic vagus nerve excitation is strengthened (pancreas islet tissue is dominated by vagus nerve), so that the secretion of pancreatic hyperglycemia, epinephrine and adrenocortical hormone is effectively inhibited, the resistance of tissue cells to insulin is eliminated, the environmental condition of an insulin receptor is improved, the energy can be rapidly enhanced, the blood sugar effect is accelerated, the hepatic glycogenolysis is inhibited, and the aims of reducing blood sugar and recovering the pancreatic islet function are fulfilled.
The probe C can be placed on three acupuncture points of Shenque, Qihai and Guanyuan of a human body, so that the energy of all tissue cells of viscera is sufficient through the multi-micro energy field in the probe C, the functional tissues are promoted to be adjusted, the qi and blood of the organism are harmonized, the collaterals are smooth, the qi and blood body fluid is better delivered to internal organs of the five viscera and the six viscera, bones of four limbs and bones, muscles and bones and skin are nourished, and the metabolism of the functional tissues of the viscera is orderly developed.
The probes D and D' are respectively placed on Zusanli points of the two legs for treatment in the morning and Sanyinjiao points of the two legs for treatment in the afternoon according to the treatment time, so that the symptoms of drinking water and frequent urination in diabetes can be effectively treated.
To test the therapeutic effect of the present invention, the following clinical trials were designed:
first, setting of experimental standard
1. Case selection criteria:
diagnostic criteria: all cases are type II diabetics, and the diagnosis standard recommended by the ADA meeting in 96 years, namely the typical clinical symptoms and signs, fasting blood sugar is more than or equal to 7.0mmo1/L, and blood sugar is more than or equal to 11.00rnmo1/L after 2 hours of meal belong to the observation range.
2. Test case criteria:
(1) inclusion criteria were:
those who meet the criteria of Western diagnosis and are not excluded.
(2) Exclusion criteria:
i, although the disease is the primary disease, the disease is accompanied by a and ketoacidosis; b. patients who are treated with insulin during severe acute infection, major surgery and trauma; c. severe liver, renal insufficiency; d. complicated with severe primary diseases of the cardiovascular, cerebrovascular and hematopoietic systems, and mental disorders.
II, if the treatment is not performed according to the prescription, the curative effect cannot be judged, or the data is not complete, and the treatment or the safety judgment is affected.
3. Grouping and treatment method
All cases come from medical wards of traditional Chinese medicine hospital in Hainan province and outpatient clinic of diabetes department, and the cases meeting the inclusion standard are randomly divided into 30 cases of acupoint energy-filling rehabilitation therapeutic apparatuses (treatment groups) and 20 cases of excellent blood sugar-reducing groups (control groups) according to the odd and even education of the numbers of hospitalization or treatment.
(1) Treatment groups: the medicine is applied to acupuncture points to realize rehabilitation therapy, and the medicine is taken orally with blood sugar lowering effect of 2.5 mg/time and Tid.
(2) Control group: 5 mg/time of blood sugar reduction, Tid, oral administration.
If the above cases are newly discovered type II diabetes, the blood sugar of the patients is still higher than the normal level after 2 weeks of diet control and exercise therapy, the patients are observed, if the patients take Chinese and western medicines for treating the diabetes before observation, the patients are observed after stopping taking the medicines for one week, all the cases are carried out under the premise of diet control and exercise therapy, any Chinese and western medicines for treating the diabetes are not taken in the treatment process, a treatment course (60 days) is observed for all the cases, the first 30 days are the first stage, the second 30 days are the second stage, and the second stage is that on the basis of the treatment of the first stage, the statistically significant cases in the two groups are reduced to 1/2 dosage of the first stage. The remaining cases were treated as in the first phase. Filling in case observation table before and after treatment, and periodically reviewing related indexes, and performing statistical treatment on all data after treatment.
Second, general data of test group
1. Sex, age and course of disease
All 50 patients, 38 men and 12 women. The minimum age was 45 years, the maximum age was 70 years, and the mean (62.1 ± 6.8) years. The shortest disease course is 1 month, the longest disease course is 5 years, and the average (1.8 +/-0.8) years.
Sex, age, and course of disease can be regarded as attributes of the patients, and the distribution of the above 50 patients is shown in table 1.
Through X2 detection, the two groups have no significant difference (P >0.05) in sex, age and disease course distribution and are comparable.
Table 1: distribution of sex, age and course of disease in two groups
Figure BDA0002388532590000101
2. Complicated peripheral neuropathy and 24h urine protein abnormality
In the merged peripheral neuropathy, the treatment group was 56.5%, the control group was 55.2%; urine protein abnormality at 24 hours, 43.5% in the treatment group and 44.8% in the control group. The distribution is shown in table 2:
table 2: two groups combined peripheral neuropathy and 24-hour urine protein abnormal distribution table (Ex%)
Group of n (number of people) The number of peripheral neuropathy patients 24 hours abnormal urinary protein
Treatment group 30 16(56.5%) 14(43.5%)
Control group 20 11(55.2%) 9(44.8%)
By the X2 detection, the combined peripheral neuropathy between the two groups has no significant difference (P >0.05) in the abnormal change of the urine protein at 24 hours, and is comparable.
3. Clinical outcome registration criteria
(1) And comprehensive therapeutic effect evaluation criteria
Refer to the therapeutic effect judgment standard in the clinical research guidelines of diabetes treatment with new Chinese medicines.
The effect is shown: clinical symptoms and physical signs disappear, fasting blood glucose FBG is less than or equal to 7.2mmol/L, or is reduced by 30%, and blood glucose PBG is less than or equal to 8.3mmol/L or is reduced by 30% after two hours.
The method has the following advantages: the clinical symptoms and physical signs are reduced, the fasting blood sugar FBG is less than or equal to 8.3mmol/L, or is reduced by 10 to 29 percent, and the blood sugar PBG is less than or equal to 10.0mmol/L or is reduced by 10 to 29 percent after two hours.
And (4) invalidation: the clinical symptoms are not obviously improved, and FBG or PBG is respectively more than or equal to 8.3 mmol/L; 10.0 mmol/L.
(2) Improving the therapeutic effect standard of peripheral neuropathy of type II diabetes
① is effective in relieving or eliminating symptoms after treatment.
② is ineffective, and there is no relief of symptoms after treatment.
(3) Improving type II diabetes and nephropathy.
① is effective in reducing urinary protein 24 hours after treatment.
② is ineffective, there is no significant decrease in uroproteinuria 24 hours after the end of treatment.
4. Observation indexes and measurement methods:
FBG and PBG were measured by the euglyco method.
24 hours urine protein assay, using radioimmunoassay.
Glycosylated hemoglobin, HBAIC chromatography.
C, titanium determination and a radioimmunoassay.
Third, analysis of experimental results
1. The two groups of the medicine are compared in the total curative effect, see table 3
Table 3: general therapeutic effect conditions (Ex%)
Group of n (number of people) Number of effective people Number of effective persons Number of invalid persons Total effective rate
Treatment group 30 9(30%) 19(63.3%) 2(6.6%) 93.33%
Control group 20 4(20%) 10(50%) 6(30%) 70%
P <0.05 by radius analysis shows improvement on type II diabetes. The treated group is obviously superior to the control group 2, and the contents of blood sugar, glycosylated hemoglobin and C peptide before and after treatment of the patients are compared in a table 4.
Table 4: comparison of blood glucose, HBIAC, C-peptide content before and after treatment (X + S)
Figure BDA0002388532590000121
Through r detection, compared with the values before treatment, the two groups can obviously reduce the values of FBG and PBG/HBAic. Can increase C peptide content after treatment. P <0.05, P <0.01, but there was no significant change in control C peptide content.
△ P is more than 0.05, compared with the control group, the PBG and HBAic values are reduced, the C peptide content is improved, the treatment group is better than the control group, △ P is less than 0.05, but the combination treatment group has no obvious difference of △△ P is less than 0.05 in the aspect of reducing FBG.
3. Two groups of peripheral neuropathy before and after treatment Table 5
Table 5: improvement of peripheral neuropathy before and after treatment in two groups (example%)
Group of n (number of people) Number of effective persons Number of invalid persons Total effective rate
Treatment group 18 14(77.8%) 4(22.22%) 77.8%
Control group 10 4(40%) 6(60%) 40%
Through the Rait analysis, P is less than 0.05, which shows that the curative effect of the treatment group is obviously superior to that of the control group in improving the type II diabetes combined peripheral neuropathy.
4. Changes in urine protein 24 hours before and after treatment in both groups are shown in Table 6
TABLE 6 two groups of urine protein changes (X + S) 24 hours before and after treatment
Figure BDA0002388532590000131
By r detection, compared with the treatment group before treatment, P of the treatment group is less than 0.05, the urine protein content in 24 hours can be obviously reduced, and the control group has no curative effect.
Fourthly, observing and concluding:
1. the therapeutic apparatus has obvious difference in the aspects of improving symptoms, reducing blood sugar and glycosylated hemoglobin and increasing the content of C peptide compared with a pure western medicine control group, and particularly shows more obvious curative effect on reducing blood sugar two hours after a meal. The reason is that the instrument activates islet cells, recovers the function of the islet, enhances the sensitivity of insulin to target cells and improves the islet resistance by stimulating the Shenque point and the projection area (Qimen point) of the pancreas on the body surface.
2. The treatment of peripheral neuropathy has obvious difference compared with a control group, and the multi-energy synthetic waves generated by the instrument promote the synchronous resonance of meridians, cells and blood of the body through the stimulation of acupuncture points, supply sufficient energy to each part of tissue system of the body through limbs and bones, effectively promote and strengthen the function of a microcirculation system and enhance the self-repairing capability of nervous tissue.
3. For type II diabetes mellitus with early kidney changes, the treated groups have obvious differences in comparison before and after treatment or comparison with the control group. The traditional Chinese medicine considers that acupuncture of three points of Shenshu, Mingmen and Yongquan has the effects of reinforcing kidney qi, exciting the kidney channel function, increasing the renal blood flow and improving local circulation, and the instrument stimulates the three points to generate the effect by mixing the thermomagnetic energy input with the frequency of a rotating magnetic field, thereby promoting the recovery of early nephropathy lesion.
4. In the treatment process, it is found that in the treatment group of significant cases, in the second stage of treatment, no significant case has blood sugar rising, and in the second stage of treatment, 3 significant cases have blood sugar rising exceeding the normal range, which shows that the instrument has the characteristics of definite, lasting and stable curative effect in the aspect of reducing blood sugar.
5. In the treatment process, 4 cases of the control group have hypoglycemia reaction, and none of the treatment groups have hypoglycemia reaction, which shows that the instrument has bidirectional regulation effect by regulating yin and yang of the organism, prevents hypoglycemia and is safe to use.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.

Claims (10)

1. A gyromagnetic rehabilitation therapy apparatus comprising: the device comprises a control circuit and at least one first probe and at least one second probe, wherein the control circuit is electrically connected with the first probe and the second probe so as to respectively provide working voltage for the first probe and the second probe;
the first probe comprises a first shell, a first human body contact surface arranged on the first shell and used for contacting with a human body, a first multi-micro-element sheet arranged in the first shell and positioned on one side of the human body contact surface, a magnet and a motor; the motor is connected with the magnet, and the motor drives the magnet to rotate when rotating to generate a rotating magnetic field; at least one first induction coil and at least one first wave-absorbing element are arranged on at least one side of the motor, the first induction coil is used for generating heat and corresponds to the first wave-absorbing element one by one, the first multi-micro-element sheet is arranged between the first induction coil and the human body contact surface and consists of multiple trace elements required by a human body, and the first wave-absorbing element is used for absorbing electromagnetic waves projected to the surface of the first wave-absorbing element and shielding an external magnetic field, wherein the electromagnetic waves are generated after the first induction coil is electrified;
the second probe comprises a second shell, a second human body contact surface arranged on the second shell and used for contacting a human body, a second multi-micro-element sheet arranged in the second shell and positioned on one side of the second human body contact surface, a second induction coil and a second wave-absorbing element made of wave-absorbing materials; the second multi-micro-element sheet is arranged between the second induction coil and the second human body contact surface, the second multi-micro-element sheet is composed of multiple trace elements required by a human body, the second wave absorbing element is used for absorbing electromagnetic wave energy projected to the surface of the wave absorbing material and shielding an external magnetic field, and the second induction coil is used for generating heat and corresponds to the second wave absorbing element one by one; the second induction coil is used for converting electric energy into heat energy, and the electromagnetic waves are generated after the second induction coil is electrified.
2. The gyromagnetic rehabilitation therapy apparatus according to claim 1, wherein the number of the first probe and the second probe is one and four, respectively.
3. The gyromagnetic rehabilitation therapy apparatus according to claim 2, wherein the first probe and the second probe are applied at positions corresponding to acupuncture points of a human body.
4. The gyromagnetic rehabilitation therapy apparatus according to claim 1, wherein said plurality of trace elements required by human body includes: chromium, zinc, magnesium, calcium, vanadium, iron, selenium, silicon, molybdenum, nickel, iodine, copper, manganese, folic acid, carotene, potassium, phosphorus, chlorine, iron, germanium, cobalt, iron folic acid-, vitamin a, vitamin B1, B2, B3, B6, B12, vitamin C, vitamin D, vitamin E, and rare earth elements.
5. The gyromagnetic rehabilitation therapy instrument according to claim 1, wherein the control circuit comprises at least one digital potentiometer, and the digital potentiometer adjusts an operating voltage output by the control circuit to the first probe and/or the second probe according to a control signal received by the control circuit and sent by a user to perform temperature adjustment operation on the first probe and/or the second probe so as to control heat generated by an induction coil in at least one of the first probe and/or at least one of the second probe.
6. The gyromagnetic rehabilitation therapy apparatus according to claim 1, wherein said motor is a brushless motor, wherein said motor speed v: v is more than or equal to 3000 r/min and less than 5000 r/min.
7. The gyromagnetic rehabilitation therapy apparatus according to claim 1, wherein the induction coil generates heat when energized, and the heat is transferred by means of heat radiation;
the heat transferred in the way of heat radiation acts on the first multi-micro-element sheet and/or the second multi-micro-element sheet to generate a multi-micro energy field containing various elements required by the human body.
8. The gyromagnetic rehabilitation therapy apparatus according to claim 1, wherein the first and second wave-absorbing elements have a U-shaped longitudinal section, the opening of the U-shape facing the human body contact surface;
the wave absorbing element partially surrounds the induction coil.
9. The gyromagnetic rehabilitation therapy apparatus of any one of claims 1 to 8, wherein the magnet is a circular wheel fixed to the output shaft of the motor, the center point of the circular wheel being offset from the rotation point of the circular wheel;
when the motor rotates, the magnet is driven to rotate, and vibration is generated.
10. The gyromagnetic rehabilitation therapy apparatus according to claim 9, wherein the surface of the human body contact surface is provided with a plurality of protrusions.
CN202010106241.XA 2020-02-21 2020-02-21 Rotary magnetic rehabilitation instrument Pending CN111249623A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010106241.XA CN111249623A (en) 2020-02-21 2020-02-21 Rotary magnetic rehabilitation instrument

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010106241.XA CN111249623A (en) 2020-02-21 2020-02-21 Rotary magnetic rehabilitation instrument

Publications (1)

Publication Number Publication Date
CN111249623A true CN111249623A (en) 2020-06-09

Family

ID=70942964

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010106241.XA Pending CN111249623A (en) 2020-02-21 2020-02-21 Rotary magnetic rehabilitation instrument

Country Status (1)

Country Link
CN (1) CN111249623A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN203208540U (en) * 2012-08-20 2013-09-25 赵贵春 Intelligent painless acupuncture instrument
CN203370102U (en) * 2013-07-15 2014-01-01 海南泰合医疗科技有限公司 Diabetes therapeutic apparatus
US20140207018A1 (en) * 2011-03-11 2014-07-24 Ronald J. Weinstock System for diagnosing and treatment of pancreas, other tissues and organs and other medical conditions
CN107595600A (en) * 2017-10-30 2018-01-19 王世杰 Acupuncture point is filled can rehabilitation probe
CN107648035A (en) * 2017-10-30 2018-02-02 王世杰 Acupuncture point is filled can therapeutic instrument for rehabilitation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140207018A1 (en) * 2011-03-11 2014-07-24 Ronald J. Weinstock System for diagnosing and treatment of pancreas, other tissues and organs and other medical conditions
CN203208540U (en) * 2012-08-20 2013-09-25 赵贵春 Intelligent painless acupuncture instrument
CN203370102U (en) * 2013-07-15 2014-01-01 海南泰合医疗科技有限公司 Diabetes therapeutic apparatus
CN107595600A (en) * 2017-10-30 2018-01-19 王世杰 Acupuncture point is filled can rehabilitation probe
CN107648035A (en) * 2017-10-30 2018-02-02 王世杰 Acupuncture point is filled can therapeutic instrument for rehabilitation

Similar Documents

Publication Publication Date Title
Park et al. Effectiveness of acupuncture for stroke: a systematic review
Garcia-Vivas et al. Acupoint catgut embedding therapy with moxibustion reduces the risk of diabetes in obese women
Lee et al. Effects of Qi‐training on anxiety and plasma concentrations of cortisol, ACTH, and aldosterone: a randomized placebo‐controlled pilot study
Kumar et al. Immediate effect of needling at CV-12 (Zhongwan) acupuncture point on blood glucose level in patients with type 2 diabetes mellitus: a pilot randomized placebo-controlled trial
Rousdy Effectiveness of acupressure at the Zusanli (ST-36) acupoint as a comfortable treatment for diabetes mellitus: a pilot study in Indonesia
Gorgey et al. Neuromuscular electrical stimulation resistance training enhances oxygen uptake and ventilatory efficiency independent of mitochondrial complexes after spinal cord injury: a randomized clinical trial
Ye et al. Analgesic effects of balanced acupuncture versus body acupuncture in low-back and leg pain patients with lumbar disc herniation, as assessed by resting-state functional magnetic resonance imaging★
CN107648035A (en) Acupuncture point is filled can therapeutic instrument for rehabilitation
CN111249623A (en) Rotary magnetic rehabilitation instrument
Yin-Qing et al. The effectiveness of electrical acupuncture stimulation in reducing levels of self-reported anxiety of lung cancer patients during palliative care: a pilot study
CN103893005B (en) A kind of intelligent abdominal part meridian point massage device
CN107595600B (en) Acupuncture point is filled can rehabilitation probe
Ali isMAil et al. Immediate fasting blood glucose response to electroacupuncture of ST36 versus CV12 in patients with type 2 diabetes mellitus: randomized controlled trial.
Elvira Influence of yoga on the blood pressure of elderly with hypertension
Lash et al. Fibromyalgia: Evolving concepts and management in primary care settings
RU2350341C1 (en) Method of irritable bowel on health resort
CN110898333A (en) Health management instrument for assisting in repairing anxiety and depression and use method
Mohamed et al. Efficacy of Implementing Acupressure Technique on Weight Reduction among Obese Adolescent
ZHANG et al. Twenty-eight cases of simple obesity of spleen and kidney yang deficiency pattern/syndrome in females treated with electroacupuncture and isolated-medicinal moxibustion
Denghong combined acupuncture-moxibustion and psychotherapy for perimenopause syndrome
Notonegoro et al. A Single Session of Acupuncture Therapy with Combination of Balance Method and Distal Point for the Treatment of Shoulder Calcific Tendinitis: A Case Report
Zhang et al. Research progress on the effect and mechanism of Tai Ji Quan in the treatment of post-stroke depression
Becvar et al. Complementary alternative medicine: Implications for family therapy
Mate et al. Newer application of Oncothermia to non-malignant diseases such as Dupuytren's contracture of the hand and chronic lower back pain lasting more than 4 weeks
Ahalya et al. Specific Naturopathic Modalities Ameliorate Glucose Homeostasis and Other Physiological Parameters in Human Diabetics

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination